Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $1.32 in the prior trading day, Precigen Inc (NASDAQ: PGEN) closed at $1.40, up 6.06%. In other words, the price has increased by $6.06 from its previous closing price. On the day, 0.68 million shares were traded. PGEN stock price reached its highest trading level at $1.455 during the session, while it also had its lowest trading level at $1.315.
Ratios:
Our goal is to gain a better understanding of PGEN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.99 and its Current Ratio is at 2.99. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
On November 18, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $7.Cantor Fitzgerald initiated its Overweight rating on November 18, 2022, with a $7 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 28 ’23 when KIRK RANDAL J bought 96,686 shares for $1.41 per share. The transaction valued at 136,327 led to the insider holds 1,096,686 shares of the business.
KINDLER JEFFREY B sold 96,686 shares of PGEN for $136,327 on Dec 28 ’23. The Director now owns 238,275 shares after completing the transaction at $1.41 per share. On Sep 22 ’23, another insider, MITCHELL DEAN J, who serves as the Director of the company, bought 25,000 shares for $1.41 each. As a result, the insider paid 35,250 and bolstered with 356,836 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PGEN now has a Market Capitalization of 348486592 and an Enterprise Value of 292728736. For the stock, the TTM Price-to-Sale (P/S) ratio is 56.81 while its Price-to-Book (P/B) ratio in mrq is 2.94. Its current Enterprise Value per Revenue stands at 47.025 whereas that against EBITDA is -3.559.
Stock Price History:
The Beta on a monthly basis for PGEN is 1.77, which has changed by 0.16666663 over the last 52 weeks, in comparison to a change of 0.23568535 over the same period for the S&P500. Over the past 52 weeks, PGEN has reached a high of $1.88, while it has fallen to a 52-week low of $0.84. The 50-Day Moving Average of the stock is -3.91%, while the 200-Day Moving Average is calculated to be 3.26%.
Shares Statistics:
The stock has traded on average 963.63K shares per day over the past 3-months and 668660 shares per day over the last 10 days, according to various share statistics. A total of 248.92M shares are outstanding, with a floating share count of 124.43M. Insiders hold about 50.71% of the company’s shares, while institutions hold 30.36% stake in the company. Shares short for PGEN as of 1713139200 were 15961619 with a Short Ratio of 16.56, compared to 1710460800 on 16910011. Therefore, it implies a Short% of Shares Outstanding of 15961619 and a Short% of Float of 10.8100004.
Earnings Estimates
The current rating of Precigen Inc (PGEN) reflects the combined expertise of 5.0 analysts actively engaged in assessing its market performance.On average, analysts expect EPS of -$0.09 for the current quarter, with a high estimate of -$0.08 and a low estimate of -$0.09, while EPS last year was -$0.1. The consensus estimate for the next quarter is -$0.08, with high estimates of -$0.06 and low estimates of -$0.09.
Analysts are recommending an EPS of between -$0.27 and -$0.37 for the fiscal current year, implying an average EPS of -$0.34. EPS for the following year is -$0.27, with 5.0 analysts recommending between -$0.13 and -$0.42.
Revenue Estimates
Based on 5 analysts’ estimates, the company’s revenue will be $38.45M in the next fiscal year. The high estimate is $104.93M and the low estimate is $7M.
